Browsing Genetics and Epidemiology by author "Cojocaru, Elena"
Now showing items 1-3 of 3
-
KIT-Associated Familial GIST Syndrome: Response to Tyrosine Kinase Inhibitors and Implications for Risk Management.
Brodey, A; Kounnis, V; Hawkes, L; Jones, RL; McVeigh, TP; et al. (OXFORD UNIV PRESS, 2022-08-05)Sporadic gastrointestinal stromal tumors (GIST) are rare tumors, with a median age at diagnosis of 60 years. Familial GISTs are very rare and typically associated with earlier onset, with an average age at diagnosis of 48 ... -
Real-world experience with doxorubicin and olaratumab in soft tissue sarcomas in England and Northern Ireland.
Gennatas, S; Chamberlain, F; Carter, T; Slater, S; Cojocaru, E; et al. (BMC, 2020-05-06)BACKGROUND: A randomised phase II trial demonstrated that the addition of olaratumab to doxorubicin significantly increased overall survival (OS) in patients with advanced soft tissue sarcomas (STS) compared to doxorubicin ... -
Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers.
Smrke, A; Younger, E; Wilson, R; Husson, O; Farag, S; et al. (AMER SOC CLINICAL ONCOLOGY, 2020-06-01)PURPOSE: Many patients with cancer, often those with rare cancers such as sarcomas, travel long distances to access expert care. The COVID-19 pandemic necessitated widespread changes in delivery of cancer care, including ...